Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone Acetate in Castration Resistant Salivary Gland Cancers
NCT02867852Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Mar 2015
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abiraterone in salivary gland cancer (SGC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Mar 2015; status: completed.
02
Drugs
abiraterone
03
Conditions
salivary gland cancer (SGC)
Beyond the preview
Go deeper on NCT02867852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867852.